The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. Metabolic reprogramming is considered a new hallmark of cancer, but it remains unclearly described in HCC. The dysregulation of the PI3K/AKT/mTOR signaling pathway is common in HCC and is, therefore, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Ling-Yu, Smit, Daniel J., Jücker, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916527/
https://www.ncbi.nlm.nih.gov/pubmed/36768977
http://dx.doi.org/10.3390/ijms24032652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916527/
https://www.ncbi.nlm.nih.gov/pubmed/36768977
http://dx.doi.org/10.3390/ijms24032652

Ejemplares similares